Mohammed A Dahab

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Topics

Molecular Docking

Squamous Cell Carcinoma

Tyrosine Kinase

Top Venues

The Journal of organic chemistry

Journal of biomolecular structure & dynamics

Future medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Hatem Hussein Bayoumi, Mohamed-Kamal Ibrahim, Mohammed A Dahab, Fathalla Khedr, Khaled El-Adl
Exploration of the VEGFR-2 inhibition activity of phthalazine derivatives: design, synthesis, cytotoxicity, ADMET, molecular docking and dynamic simulation. RSC advances 14 (30) (2024)
Hatem Hussein Bayoumi, Mohamed-Kamal Ibrahim, Mohammed A Dahab, Fathalla Khedr, Khaled El-Adl
Rationale, in silico docking, ADMET profile, design, synthesis and cytotoxicity evaluations of phthalazine derivatives as VEGFR-2 inhibitors and apoptosis inducers. RSC advances 14 (37) (2024)
Hatem Hussein Bayoumi, Mohamed-Kamal Ibrahim, Mohammed A Dahab, Fathalla Khedr, Khaled El-Adl
Rationale, in silico docking, ADMET profile, design, synthesis and cytotoxicity evaluations of phthalazine derivatives as VEGFR-2 inhibitors and apoptosis inducers. RSC advances 14 (37) (2024)
Hatem Hussein Bayoumi, Mohamed-Kamal Ibrahim, Mohammed A Dahab, Fathalla Khedr, Khaled El-Adl
Exploration of the VEGFR-2 inhibition activity of phthalazine derivatives: design, synthesis, cytotoxicity, ADMET, molecular docking and dynamic simulation. RSC advances 14 (30) (2024)
Eman A Sobh, Mohammed A Dahab, Eslam B Elkaeed, Aisha A Alsfouk, Ibrahim M Ibrahim, Ahmed M Metwaly, Ibrahim H Eissa
Discovery of new thieno[2,3- d ]pyrimidines as EGFR tyrosine kinase inhibitors for cancer treatment. Future medicinal chemistry (2023)
Hazem Elkady, Osama A El-Dardir, Elwan Alaa, Mohammed S Taghour, Hazem A Mahdy, Mohammed A Dahab, Eslam B Elkaeed, Bshra A Alsfouk, Ibrahim M Ibrahim, Dalal Z Husein, Elsayed E Hafez, Amira Muhammad Galal Darwish, Ahmed M Metwaly, Ibrahim H Eissa
Synthesis, biological evaluation and computer-aided discovery of new thiazolidine-2,4-dione derivatives as potential antitumor VEGFR-2 inhibitors. RSC advances 13 (40) (2023)
Eman A Sobh, Mohammed A Dahab, Eslam B Elkaeed, Bshra A Alsfouk, Ibrahim M Ibrahim, Ahmed M Metwaly, Ibrahim H Eissa
A novel thieno[2,3-d]pyrimidine derivative inhibiting vascular endothelial growth factor receptor-2: A story of computer-aided drug discovery. Drug development research (2023)
Hazem A Mahdy, Hazem Elkady, Mohammed S Taghour, Elwan Alaa, Mohammed A Dahab, Mohamed A Elkady, Elsayed Ge Elsakka, Eslam B Elkaeed, Bshra Ali A Alsfouk, Ibrahim M Ibrahim, Ibrahim H Eissa, Ahmed M Metwaly
New theobromine derivatives inhibiting VEGFR-2: design, synthesis, antiproliferative, docking and molecular dynamics simulations. Future medicinal chemistry (2023)
Eman A Sobh, Mohammed A Dahab, Eslam B Elkaeed, Aisha A Alsfouk, Ibrahim M Ibrahim, Ahmed M Metwaly, Ibrahim H Eissa
Computer aided drug discovery (CADD) of a thieno[2,3- d ]pyrimidine derivative as a new EGFR inhibitor targeting the ribose pocket. Journal of biomolecular structure & dynamics (2023)
Mohammed A Dahab, Hazem A Mahdy, Hazem Elkady, Mohammed S Taghour, Alaa Elwan, Mohamed A Elkady, Elsayed G E Elsakka, Eslam B Elkaeed, Aisha A Alsfouk, Ibrahim M Ibrahim, Ahmed M Metwaly, Ibrahim H Eissa
Semi-synthesized anticancer theobromine derivatives targeting VEGFR-2: in silico and in vitro evaluations. Journal of biomolecular structure & dynamics (2023)
Eman A Sobh, Mohammed A Dahab, Eslam B Elkaeed, Aisha A Alsfouk, Ibrahim M Ibrahim, Ahmed M Metwaly, Ibrahim H Eissa
Design, synthesis, docking, MD simulations, and anti-proliferative evaluation of thieno[2,3- d ]pyrimidine derivatives as new EGFR inhibitors. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Frédéric Vuillermet, Mohammed A Dahab, Dalia Abdelhamid, Dilan E Polat, Monica A Gill, André M Beauchemin
Synthesis of 1,2,4-Triazinones Exploiting the Reactivity of Diazadiene and N -Isocyanate Intermediates. The Journal of organic chemistry 88 (4) (2023)
Frédéric Vuillermet, Mohammed A Dahab, Dalia Abdelhamid, Dilan E Polat, Monica A Gill, André M Beauchemin
Synthesis of 1,2,4-Triazinones Exploiting the Reactivity of Diazadiene and N -Isocyanate Intermediates. The Journal of organic chemistry (2023)
Elwan Alaa, Abdallah E Abdallah, Hazem A Mahdy, Mohammed A Dahab, Mohammed S Taghour, Eslam B Elkaeed, Ahmed B M Mehany, Ahmed Nabeeh, Mohammed Adel, Aisha A Alsfouk, Hazem Elkady, Ibrahim H Eissa
Modified Benzoxazole-Based VEGFR-2 Inhibitors and Apoptosis Inducers: Design, Synthesis, and Anti-Proliferative Evaluation. Molecules (Basel, Switzerland) 27 (15) (2022)
Mohammed M Alanazi, Hazem Elkady, Nawaf A Alsaif, Ahmad J Obaidullah, Hamad M Al Kahtani, Manal M Alanazi, Madhawi A Alharbi, Ibrahim H Eissa, Mohammed A Dahab
New quinoxaline-based VEGFR-2 inhibitors: design, synthesis, and antiproliferative evaluation with in silico docking, ADMET, toxicity, and DFT studies. RSC advances 11 (48) (2021)
Mohammed A Dahab, Mostafa M Hegazy, Hatem S Abbass
Hordatines as a Potential Inhibitor of COVID-19 Main Protease and RNA Polymerase: An In-Silico Approach. Natural products and bioprospecting 10 (6) (2020)